Related Experiment Video

Updated: May 14, 2026

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
05:55

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

CD21 positive B cell: a novel target for treatment of multiple sclerosis

Mojtaba Farjam1, Azin Ebrahimpour, Bahareh Fakhraei

  • 1Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. mfarjam@sums.ac.ir

Medical Hypotheses
|February 7, 2013
PubMed

Insights

Multiple sclerosis (MS) may be linked to Epstein-Barr virus (EBV). Targeting CD21 on EBV-infected B cells could offer a new therapeutic strategy for MS treatment.

Area of Science:

  • Immunology
  • Virology
  • Neurology

Background:

  • Multiple sclerosis (MS) lacks a known etiology, but environmental factors like Epstein-Barr virus (EBV) are implicated.
  • EBV resides in CD21-positive B cells, hindering eradication and MS treatment.
  • Current EBV eradication methods have not effectively modulated MS progression.

Purpose of the Study:

  • To propose a novel therapeutic strategy targeting CD21 on EBV-infected B cells for MS treatment.
  • To investigate the role of EBV in MS pathogenesis and predisposition.
  • To suggest a sequential study plan for testing this immunopharmacological approach.

Main Methods:

  • Hypothesizing a targeted therapy against CD21-expressing B cells harboring EBV.
  • Proposing a sequential study design to validate the therapeutic hypothesis.
  • Analyzing the immunopharmacological effects of targeting EBV-infected B cells.

Main Results:

  • The study proposes a novel hypothesis for MS treatment.
  • A sequential study plan is outlined to test the hypothesis.
  • The research aims to clarify EBV's role in MS.

Conclusions:

  • Targeting CD21 on EBV-infected B cells presents a potential immunopharmacological strategy for MS.
  • This approach may lead to effective treatment for MS.
  • Further research will elucidate EBV's contribution to MS etiology.

More Related Videos

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography09:41

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Published on: January 20, 2023

Murine Model of CD40-activation of B cells12:24

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

Related Concept Videos

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...